Evidence map›Paper›PMID 36962537›Full record

ArticlePLOS global public health2022

Low knowledge about hepatitis B prevention among pregnant women in Kinshasa, Democratic Republic of Congo.

Sahal Thahir, Samantha E Tulenko, Patrick Ngimbi, Sarah Ntambua, Jolie Matondo, Kashamuka Mwandagalirwa, Martine Tabala, Didine Kaba, Marcel Yotebieng, Jonathan B Parr and 1 more

Full text read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sahal ThahirDivision of Infectious Diseases, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0002-2639-2909
Samantha E TulenkoDepartment of Epidemiology, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0002-1711-0666
Patrick NgimbiKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
Sarah NtambuaKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
Jolie MatondoKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
Kashamuka MwandagalirwaKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
Martine TabalaKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
Didine KabaKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
Marcel YotebiengDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, New York, New York, United States of America.
Jonathan B ParrDivision of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0002-4465-9830
Peyton ThompsonDivision of Infectious Diseases, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0002-9679-9763

Funding

"Enhancing Cancer Research in Central Africa IeDEA"U01AI096299 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Denis Nash, Marcel Yotebieng · 2011 to 2026
$35.8M
Long term outcomes of therapy in women initiated on lifelong ART because of pregnancy in DR CongoR01HD087993 · NICHD · OHIO STATE UNIVERSITY · PI BABAKAZO, PELAGIE DIAMBALULA, YOTEBIENG, MARCEL · 2016 to 2020
$3.1M
Characterizing Hepatitis B Transmission in Congolese ChildrenK08AI148607 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THOMPSON, PEYTON J · 2020 to 2024
$1.0M
The impact of a Hepatitis B birth dose vaccine on HBV immunogenicity and incidence in children in the DRCF30AI164818 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TULENKO, SAMANTHA · 2021 to 2024
$180k
NIAID NIH HHS F30 AI164818NIAID NIH HHS K08 AI148607NIAID NIH HHS U01 AI096299NICHD NIH HHS R01 HD087993Wellcome Trust
6 · The paper itself

Abstract

Infants infected perinatally with hepatitis B (HBV) are at the highest risk of developing chronic hepatitis and associated sequelae. Prevention of mother-to-child transmission (PMTCT) of HBV requires improved screening and awareness of the disease. This study evaluated existing HBV knowledge among pregnant mothers (n = 280) enrolled in two HBV studies in urban maternity centers in Kinshasa, Democratic Republic of the Congo. All mothers responded to three knowledge questions upon study enrollment. Baseline levels of knowledge related to HBV transmission, treatment, prevention, and symptoms were low across all participants: 68.8% did not know how HBV was transmitted, 70.7% did not know how to prevent or treat HBV MTCT, and 79.6% did not know signs and symptoms of HBV. Over half of participants responded "I don't know" to all questions. HBV-positive women who participated in both studies (n = 46) were asked the same questions during both studies and showed improved knowledge after screening and treatment, despite no formal educational component in either study (p < 0.001). These findings highlight the need for intensified education initiatives in highly endemic areas to improve PMTCT efforts.

Identifiers

PMID36962537
PMCPMC10021814

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read110
identifiers read9
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.